相关实验视频

Updated: Jan 15, 2026

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure
09:38

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure

Published on: August 11, 2017

9.2K

奥西默提尼布加上强化放射治疗治疗晚期EGFR突变非小细胞肺癌:一个多中心,单臂,第二阶段试验

Sagus Sampath1, Sawsan Rashdan2,3, Puneeth Iyengar3,4

  • 1Department of Radiation Oncology, City of Hope National Medical Center, Duarte, CA, USA.

EClinicalMedicine
|October 7, 2025
PubMed
概括

将放射治疗添加到奥西默蒂尼布治疗中,显著改善了晚期EGFR突变非小细胞肺癌患者的无进展生存率. 这种组合疗法显示出有前途的疗效,并且耐受性良好,提供了潜在的少毒性选择.

关键词:
整合 整合 整合在EGFR突变的非小细胞肺癌中.肺炎是一种肺炎.立体性辐射疗法是一种立体性辐射疗法.

更多相关视频

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids08:52

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids

Published on: November 22, 2021

4.5K
Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib09:38

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib

Published on: June 26, 2019

8.4K

相关概念视频

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.6K